1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014

Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014" provides data on the Ichthyosis Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ichthyosis Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ichthyosis Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Ichthyosis Vulgaris 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Ichthyosis Vulgaris Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
ORFAGEN 24
Clinical Trial Overview of ORFAGEN 24
Laboratoires Pierre Fabre SA 25
Clinical Trial Overview of Laboratoires Pierre Fabre SA 25
GlaxoSmithKline plc 26
Clinical Trial Overview of GlaxoSmithKline plc 26
Galderma S.A. 27
Clinical Trial Overview of Galderma S.A. 27
Clinical Trial Overview of Top Institutes / Government 28
FDA Office of Orphan Products Development 28
Clinical Trial Overview of FDA Office of Orphan Products Development 28
National Human Genome Research Institute 29
Clinical Trial Overview of National Human Genome Research Institute 29
The National Institute of Allergy and Infectious Diseases 30
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 30
Uppsala University 31
Clinical Trial Overview of Uppsala University 31
Northwestern University 32
Clinical Trial Overview of Northwestern University 32
Hopital Necker-Enfants Malades 33
Clinical Trial Overview of Hopital Necker-Enfants Malades 33
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
National Institute of Arthritis and Musculoskeletal and Skin Diseases 35
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 35
Five Key Clinical Profiles 36
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 55

List of Tables
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region, 2014* 6
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 9
Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 11
Ichthyosis Vulgaris Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2014* 13
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by ORFAGEN, 2014* 24
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 25
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 26
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2014* 27
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014* 28
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Human Genome Research Institute, 2014* 29
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 30
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University, 2014* 31
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 32
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital Necker-Enfants Malades, 2014* 33
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 34
Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 35

List of Figures
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 9
Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 10
Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2014* 13
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
GlobalData Methodology 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.